Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis
出版年份 2018 全文链接
标题
Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis
作者
关键词
-
出版物
PHARMACOGENOMICS JOURNAL
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-09-24
DOI
10.1038/s41397-018-0054-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case–control study
- (2017) Ju-E Liu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A possible role for HLA-DRB1*04:06 in statin-related myopathy in Japanese patients
- (2016) Kimie Sai et al. Drug Metabolism and Pharmacokinetics
- Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk
- (2015) Qingtao Hou et al. MEDICINE
- Meta-Analysis of theSLCO1B1c.521T>C Variant Reveals Slight Influence on the Lipid-Lowering Efficacy of Statins
- (2015) Ye Dou et al. Annals of Laboratory Medicine
- SLCO1B1 Polymorphism is not associated with Risk of Statin-Induced Myalgia/Myopathy in a Czech Population
- (2015) Michal Vrablík MEDICAL SCIENCE MONITOR
- Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2
- (2014) Marco Ferrari et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy
- (2013) Jacqueline S. Danik et al. AMERICAN HEART JOURNAL
- SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink
- (2013) D F Carr et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions
- (2012) QiPing Feng et al. PHARMACOGENOMICS
- SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia
- (2011) Paulo Caleb Junior Lima Santos et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Cerivastatin, genetic variants, and the risk of rhabdomyolysis
- (2011) Kristin D. Marciante et al. Pharmacogenetics and Genomics
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
- (2010) L A Donnelly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- PharmGKB very important pharmacogene: SLCO1B1
- (2010) Connie Oshiro et al. Pharmacogenetics and Genomics
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search